Abstract
An 81-year-old man with a history of prostate cancer, status post radiation therapy, was referred for a prostate-specific membrane antigen (PSMA) PET/CT scan. Fluorine-18 DCF-Pyl (Pylarify) PSMA PET/CT showed focal increased radiotracer uptake at the right prostate and bilateral iliac chain metastatic lymph nodes. The same PSMA PET/CT showed focal increased radiotracer uptake at the junction of the mid to lower esophagus. 18 F-FDG PET/CT identified a large hypermetabolic esophageal mass in the mid to lower esophagus, showing a greater extent of esophageal disease than the PSMA PET/CT. An endoscopic biopsy confirmed poorly differentiated esophageal squamous cell carcinoma.
| Original language | English |
|---|---|
| Pages (from-to) | 774-777 |
| Number of pages | 4 |
| Journal | Clinical Nuclear Medicine |
| Volume | 50 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 1 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Humans
- Male
- Positron Emission Tomography Computed Tomography
- Esophageal Neoplasms/diagnostic imaging
- Aged, 80 and over
- Fluorodeoxyglucose F18
- Esophageal Squamous Cell Carcinoma
- Carcinoma, Squamous Cell/diagnostic imaging
- Glutamate Carboxypeptidase II/metabolism
- Antigens, Surface
Fingerprint
Dive into the research topics of 'Different Appearances of Esophageal Squamous Cell Carcinoma in 18 F-PSMA PET/CT Versus 18 F-FDG PET/CT'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver